Filter posts

Fireside Chat: James Noble Says Go for IPO

“Go for it,” was the parting advice James Noble, CEO and co-founder of Adaptimmune, had …

Biotech Policy Outlook at #BIF15: 21st Century Cures, IPR, TPP, and PDUFA VI

To even the most casual observer, 2015 has been a big year in the biotech …

BIO Investor Forum Session Recap: Precision Medicine: Leveraging National Genomic Databases for Ther...

As the price point for full genome analysis falls through the $1,000 per person milestone, …

BIO Investor Forum Newly Added Sessions - Digital Health Spotlights

We are pleased to announce that two “digital health spotlight” sessions have been added to …

See What’s New at the 2015 BIO Investor Forum

The 2015 BIO Investor Forum is just two weeks away, and it’s gearing up to …

Emerging Themes in Personalized Medicine

The adoption of Personalized Medicine is being driven by the omnipresence of Next-Generation Sequencing (NGS), …

5 Tips for a BIO 2016 Session Proposal: Help us Imagine the Future

As you hopefully know we have an open call for session ideas and proposals for …

BIO Investor Forum’s Impressive Program Lineup

This week, BIO announced the final program and speakers for the 14th Annual BIO Investor …

Discover Trends and Investment Opportunities at the BIO Investor Forum

The 2015 BIO Investor Forum in San Francisco is shaping up to be a must-attend event …

Share your Cutting Edge Ideas at the 2016 BIO International Convention

After a record-breaking event this year in Philadelphia, the BIO International Convention will return to …